MetLife Investment Management
CGEM icon

MetLife Investment Management’s Cullinan Oncology CGEM Stock Holding History

MetLife Investment Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$651K Buy
35,746
+4,930
+16% +$73.2K ﹤0.01% 1768
2026
Q1 		$438K Hold
30,816
– – ﹤0.01% 1821
2025
Q4 		$319K Buy
30,816
+7,571
+33% +$68.3K ﹤0.01% 2032
2025
Q3 		$138K Sell
23,245
-8,209
-26% -$60.1K ﹤0.01% 2503
2025
Q2 		$237K Hold
31,454
– – ﹤0.01% 2103
2025
Q1 		$238K Sell
31,454
-604
-2% -$5.8K ﹤0.01% 2109
2024
Q4 		$390K Buy
32,058
+2,217
+7% +$31.9K ﹤0.01% 1929
2024
Q3 		$500K Buy
29,841
+7,115
+31% +$126K ﹤0.01% 1784
2024
Q2 		$396K Buy
22,726
+9,389
+70% +$200K ﹤0.01% 1855
2024
Q1 		$227K Hold
13,337
– – ﹤0.01% 2127
2023
Q4 		$136K Hold
13,337
– – ﹤0.01% 2450
2023
Q3 		$121K Hold
13,337
– – ﹤0.01% 2484
2023
Q2 		$144K Sell
13,337
-3,088
-19% -$32.8K ﹤0.01% 2472
2023
Q1 		$168K Hold
16,425
– – ﹤0.01% 2324
2022
Q4 		$173K Sell
16,425
-3,464
-17% -$42.1K ﹤0.01% 2336
2022
Q3 		$255K Buy
19,889
+4,491
+29% +$60.5K ﹤0.01% 2130
2022
Q2 		$197K Hold
15,398
– – ﹤0.01% 2324
2022
Q1 		$161K Buy
15,398
+5,590
+57% +$75.5K ﹤0.01% 2479
2021
Q4 		$151K Hold
9,808
– – ﹤0.01% 2228
2021
Q3 		$221K Buy
9,808
+3,710
+61% +$99.2K ﹤0.01% 2025
2021
Q2 		$157K Hold
6,098
– – ﹤0.01% 2303
2021
Q1 		$254K Buy
+6,098
New +$248K ﹤0.01% 1919

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

MetLife Investment Management's CGEM Position: Q2 2026 in Review

MetLife Investment Management increased its Cullinan Oncology (CGEM) stake by 16% in Q2 2026, buying an estimated $73.2K and bringing the position to 35,746 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #1768.

MetLife Investment Management first reported a position in CGEM in Q1 2021 and has held it in 22 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • MetLife Investment Management held 35,746 shares of Cullinan Oncology worth $651K as of Q2 2026.
  • MetLife Investment Management bought 4,930 Cullinan Oncology shares in Q2 2026, an estimated $73.2K.
  • Cullinan Oncology made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1768 holding.
  • MetLife Investment Management first reported a position in Cullinan Oncology in Q1 2021 and has held it in 22 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.